SoCal.Startups is building the most comprehensive resource for Southern California's tech scene.
SoCal.Startups
Be an early user
AFFINITY BIOSENSORS LLC hero photo
AFFINITY BIOSENSORS LLC logo

AFFINITY BIOSENSORS LLC

Santa Barbara, CA
LAST FUNDING
$48.5M
Series A

Affinity Biosensors’ LifeScale platform delivers rapid, high-throughput phenotypic antimicrobial susceptibility testing in under four hours, empowering clinical labs to make timely antibiotic decisions and combat drug-resistant infections.

Funding history

RoundAmount
Series A$48.5M
SEC Form D filed
Jul 24, 2026·Jul 16, 2026·May 21, 2026·Mar 23, 2026·Dec 26, 2024·Dec 2, 2024·Jun 12, 2024·Jun 7, 2024·Mar 22, 2024·Dec 1, 2023·Nov 14, 2023·Oct 10, 2023·Jul 28, 2023·Feb 17, 2023·Dec 7, 2022·Nov 17, 2021·Nov 4, 2020·Feb 3, 2020·Aug 20, 2019·Dec 17, 2018·Dec 12, 2017·Dec 5, 2017·Aug 23, 2016·Jun 22, 2016·Feb 9, 2015·Jan 27, 2015·Dec 23, 2013·Jul 20, 2011·May 18, 2010

About AFFINITY BIOSENSORS LLC

How much funding has AFFINITY BIOSENSORS LLC raised?

AFFINITY BIOSENSORS LLC has raised $48.5M in total funding. The most recent round was Series A.

Where is AFFINITY BIOSENSORS LLC headquartered?

AFFINITY BIOSENSORS LLC is headquartered in Santa Barbara, CA.

What does AFFINITY BIOSENSORS LLC do?

Affinity Biosensors’ LifeScale platform delivers rapid, high-throughput phenotypic antimicrobial susceptibility testing in under four hours, empowering clinical labs to make timely antibiotic decisions and combat drug-resistant infections.

What problem does AFFINITY BIOSENSORS LLC solve?

Clinicians need fast, accurate antibiotic susceptibility test results -- especially for dangerous resistant Gram-negative bacteria in positive blood cultures -- to act quickly on patient treatment.

What's AFFINITY BIOSENSORS LLC's solution?

LifeScale, a rapid AST (antibiotic susceptibility testing) system using population-profiling technology with automated sample inoculation, incubation, reading, and reporting, delivering results in about 4.5 hours.

What makes AFFINITY BIOSENSORS LLC different?

FDA-cleared (a third clearance is cited), with published accuracy data benchmarked against standard-of-care methods (WalkAway, Phoenix, Vitek) and under 10 minutes of added hands-on technician time.

What makes AFFINITY BIOSENSORS LLC notable?

Affinity Biosensors was co-founded by MIT professor Scott Manalis, known for his microfluidic mass-sensing research, along with CEO Dr. Ken Babcock.

Leadership

Kenneth Babcock
Executive Officer, Director
Michael E. Pfau
Executive Officer
Jeffrey Hawkins
Director
James Iuliano
Director
L. Robert Johnson
Director
Charles Mamrak
Director
Industry
B2B
HQ
Santa Barbara, CA
Raised
$48.5M
Stage
Series A

Related terms

❝ Cite this page

Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated September 3, 2026.

MLA
"AFFINITY BIOSENSORS LLC: Funding & Investors." SoCal.Startups, September 3, 2026, https://socalstartups.io/companies/affinity-biosensors-llc. Accessed September 29, 2026.
APA
SoCal.Startups. (2026). AFFINITY BIOSENSORS LLC: Funding & Investors. Retrieved September 29, 2026, from https://socalstartups.io/companies/affinity-biosensors-llc
WIKIPEDIA (CITE WEB)
{{cite web |title=AFFINITY BIOSENSORS LLC: Funding & Investors |url=https://socalstartups.io/companies/affinity-biosensors-llc |website=SoCal.Startups |access-date=September 29, 2026}}
🏷 Embed this badge

Building or fundraising? Add this to your site to show you're listed on SoCal.Startups — the link back helps other founders and investors find you here too.

AFFINITY BIOSENSORS LLC featured on SoCal.Startups
HTML
<a href="https://socalstartups.io/companies/affinity-biosensors-llc" target="_blank" rel="noopener"><img src="https://socalstartups.io/badge.svg" width="220" height="52" alt="AFFINITY BIOSENSORS LLC featured on SoCal.Startups" /></a>
MARKDOWN
[![AFFINITY BIOSENSORS LLC featured on SoCal.Startups](https://socalstartups.io/badge.svg)](https://socalstartups.io/companies/affinity-biosensors-llc)